Teva Rise Launches Global Push for Next-Gen Healthcare Tech

Teva Pharmaceutical Industries has launched Teva Rise, a global innovation platform built to speed up how new technologies move into healthcare.

The company introduced the effort today as a way to link its business units with startups in digital health and biotech. With Teva Rise, Teva aims to solve real-world pharmaceutical problems while pushing its Pivot to Growth strategy forward.

Mark Sabag, EVP International Markets and global sponsor of the program, called it a major step for the company. “This is an exciting first for Teva,” he said. “By partnering with startups worldwide, we can unlock smarter solutions, channel tens of millions of dollars into innovation, and deliver meaningful value to patients everywhere.”

Also Read: India's Path to Billion-Dollar Drugs: Building a Strong Ecosystem

The launch comes as digital tools and data-driven processes reshape drug development, manufacturing, and patient care. The platform will give startups a chance to test their solutions in real settings and scale them across Teva’s global network.

The program begins with an open call for startups to address seven challenges across R&D, manufacturing, supply chain, and commercial operations. These focus areas include predictive biologics platforms, AI-driven clinical trial design, and digital tools that improve the patient experience, especially for long-acting injectables.

Selected companies will pilot their technologies with Teva and explore long-term integration across its operations. Richard Francis, Teva’s President and CEO, said, “Teva Rise is a powerful example of our Pivot to Growth strategy in action. By bringing together the best minds and technologies, we’re not just modernizing our operations—we’re transforming the future of healthcare for patients everywhere.”